Evaluation of CRISPR gene-editing tools in zebrafish

被引:11
|
作者
Uribe-Salazar, Jose M. [1 ,2 ,3 ]
Kaya, Gulhan [1 ,2 ]
Sekar, Aadithya [1 ,2 ]
Weyenberg, KaeChandra [1 ,2 ]
Ingamells, Cole [1 ,2 ]
Dennis, Megan Y. [1 ,2 ,3 ]
机构
[1] Univ Calif Davis, Sch Med, Genome Ctr, MIND Inst, Davis, CA 95616 USA
[2] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA 95616 USA
[3] Univ Calif Davis, Integrat Genet & Genom Grad Grp, Davis, CA 95616 USA
基金
美国国家卫生研究院;
关键词
Danio rerio; Zebrafish; CRISPR; Cas9; Gene knockout; CIRCLE-seq; RNA-seq; CAS9; NUCLEASE; WEB TOOL; GENOME; TARGET; SEQUENCE; QUANTIFICATION; MUTAGENESIS; CLEAVAGE; CHOPCHOP; DESIGN;
D O I
10.1186/s12864-021-08238-1
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background Zebrafish have practical features that make them a useful model for higher-throughput tests of gene function using CRISPR/Cas9 editing to create 'knockout' models. In particular, the use of G(0) mosaic mutants has potential to increase throughput of functional studies significantly but may suffer from transient effects of introducing Cas9 via microinjection. Further, a large number of computational and empirical tools exist to design CRISPR assays but often produce varied predictions across methods leaving uncertainty in choosing an optimal approach for zebrafish studies. Methods To systematically assess accuracy of tool predictions of on- and off-target gene editing, we subjected zebrafish embryos to CRISPR/Cas9 with 50 different guide RNAs (gRNAs) targeting 14 genes. We also investigate potential confounders of G(0)-based CRISPR screens by assaying control embryos for spurious mutations and altered gene expression. Results We compared our experimental in vivo editing efficiencies in mosaic G(0) embryos with those predicted by eight commonly used gRNA design tools and found large discrepancies between methods. Assessing off-target mutations (predicted in silico and in vitro) found that the majority of tested loci had low in vivo frequencies (< 1%). To characterize if commonly used 'mock' CRISPR controls (larvae injected with Cas9 enzyme or mRNA with no gRNA) exhibited spurious molecular features that might exacerbate studies of G(0) mosaic CRISPR knockout fish, we generated an RNA-seq dataset of various control larvae at 5 days post fertilization. While we found no evidence of spontaneous somatic mutations of injected larvae, we did identify several hundred differentially-expressed genes with high variability between injection types. Network analyses of shared differentially-expressed genes in the 'mock' injected larvae implicated a number of key regulators of common metabolic pathways, and gene-ontology analysis revealed connections with response to wounding and cytoskeleton organization, highlighting a potentially lasting effect from the microinjection process that requires further investigation. Conclusion Overall, our results provide a valuable resource for the zebrafish community for the design and execution of CRISPR/Cas9 experiments.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Evaluation of CRISPR gene-editing tools in zebrafish
    José M. Uribe-Salazar
    Gulhan Kaya
    Aadithya Sekar
    KaeChandra Weyenberg
    Cole Ingamells
    Megan Y. Dennis
    [J]. BMC Genomics, 23
  • [2] 'ChatGPT for CRISPR' creates new gene-editing tools
    Callaway, Ewen
    [J]. NATURE, 2024, 629 (8011) : 272 - 272
  • [3] CRISPR snapshots of a gene-editing tool
    Krasteva, Petya V.
    [J]. NATURE METHODS, 2014, 11 (04) : 365 - 365
  • [4] CRISPR snapshots of a gene-editing tool
    Petya V Krasteva
    [J]. Nature Methods, 2014, 11 : 365 - 365
  • [5] Progress in Gene-Editing Technology of Zebrafish
    Li, Yanling
    Jia, Zhipeng
    Zhang, Shuchao
    He, Xiaozhen
    [J]. BIOMOLECULES, 2021, 11 (09)
  • [6] CRISPR: a journey of gene-editing based medicine
    Golkar, Zhabiz
    [J]. GENES & GENOMICS, 2020, 42 (12) : 1369 - 1380
  • [7] CRISPR: a journey of gene-editing based medicine
    Zhabiz Golkar
    [J]. Genes & Genomics, 2020, 42 : 1369 - 1380
  • [8] CRISPR gene-editing therapies for hypertrophic cardiomyopathy
    Alanna Strong
    [J]. Nature Medicine, 2023, 29 (2) : 305 - 306
  • [9] CasX: a new and small CRISPR gene-editing protein
    Yang, Hui
    Patel, Dinshaw J.
    [J]. CELL RESEARCH, 2019, 29 (05) : 345 - 346
  • [10] CasX: a new and small CRISPR gene-editing protein
    Hui Yang
    Dinshaw J. Patel
    [J]. Cell Research, 2019, 29 : 345 - 346